Author | J. Brantley Thrasher, MD


Challenges remain for active surveillance in low-risk PCa

February 01, 2018


“Active surveillance continues to gain traction as a management strategy for low-risk prostate cancer in the United States. However, barriers still exist and challenges remain for both the treating urologist and the patient,” writes J. Brantley Thrasher, MD.

Renal biopsy may alter management in high-risk patients

January 01, 2016


In this interview, E. Jason Abel, MD, discusses biopsy’s role in small and large renal masses, associated risks, and when patients can be safely observed.

Immunotherapy will define new era of GU cancer care

December 31, 2014


In this interview, Arie Belldegrun, MD, discusses the benefits of cancer immunotherapy, the importance of a multidisciplinary treatment approach, and what the future holds for this treatment.

All American Urological Association members can thrive under 'big tent,' says AUA president

August 01, 2012


The AUA is challenged with staying fair and relevant to all urologists under the "big tent," even though academic-employed urologists, non-academic-employed urologists, those in private practice, and those in large group practices may have different priorities and problems.